The report “Mice Model Market by Type (Inbred, Knockout, Hybrid), Technology (Microinjection, Embryonic stem Cell), Disease (Oncology, Diabetes), Service (Breeding, Quarantine, Genetic testing) & Care Products (Bedding, Feed) - Analysis & Global Forecast to 2020”, This report studies the global mice model market for the forecast period of 2015 to 2020. This market is expected to reach USD 1.49 Billion by 2020 from USD 1.05 Billion in 2015, at a CAGR of 7.1%.
Browse 119 market tables and 47 figures spread through 249 pages and in-depth TOC on "Mice Model Market"
Early buyers will receive 10% customization on this report.
The global mice model market is segmented on the basis of type, technology, disease, service, care and regions. The report also provides market for mice care products, by type.
By type, the mice model market is categorized into inbred mice, genetically modified mice (knockout, knock-in), conditioned/surgically modified mice, hybrid/congenic mice, outbred mice, and spontaneous mutant mice. The inbred mice are estimated to account for the largest share of the global mice model market, by type. However, knockout mice models are expected to be the fastest-growing market segment owing to high investments in the development of new and innovative knockout models that also increases the application areas for the models.
Talk To Our Research Analyst for More Info@
On the basis of technology, the market is segmented into microinjection, embryonic stem cell injection, nuclear transferase, and other technologies. Other technologies include genetically modified sperm-mediated gene transfer, virus/vector mediated gene transfer, liposome-mediated DNA & electroporation of DNA, biolistics, and CRISPR/Cas9, TALENs & ZFN. In 2015, microinjection technology is expected to command the largest share of the global mice model market, by technology.
The mice model market has been further segmented by disease, which includes oncology, immunology & inflammation-related diseases, diabetes, cardiovascular diseases, central nervous system-related diseases, metabolism & regulation-related diseases, and other diseases. Other diseases include rare diseases and renal disorders. In 2015, the oncology segment is expected to command the largest share of the global mice model market, by disease.
Get the Customized Information@
The mice model market, by service, has been segmented into breeding, quarantine, rederivation, cryopreservation, genetic testing, model in-licensing, and other services. Other services include surgical, line rescue, and in vivo pharmacology services. In 2015, breeding services are expected to command the largest share of the global mice model market, by services.
The market also covers the mice care products market, by type, which includes bedding, cages, feed, and other products (gnotobiotic equipment, water systems, and accessories like washing systems, logistics, water purification systems, sound absorption panels). In 2015, cages command the largest share of the global mice care products market.
On the basis of region, the global market is divided into North America, Europe, Asia-Pacific, and the Rest of the World. In 2015, North America is poised to account for the largest share of the mice model market, followed by Europe and Asia-Pacific. However, the Asia-Pacific market is slated to grow at the highest CAGR during the forecast period.
Ongoing innovations in mice models, personalized medicine fuelling the demand for personalized humanized mice models, continuous support in the form of investments and grants, and increase in R&D activities of pharmaceutical industries are some of the factors that are expected to drive the growth of the global mice model market in the coming years.
Charles River Laboratories International, Inc. (U.S.), The Jackson Laboratory (U.S.), Taconic Biosciences, Inc. (U.S.), Envigo (U.K.), Covance, Inc. (U.S.), Janvier Labs France), Harbour Antibodies BV (Netherlands), Transgenic, Inc. (Japan), genOway SA (France), and SAGE Labs, Inc. (U.S.) are some of the key players in the mice model market worldwide.
MarketsandMarkets is the world’s No. 2 firm in terms of annually published premium market research reports. Serving 1700 global fortune enterprises with more than 1200 premium studies in a year, M&M is catering to a multitude of clients across 8 different industrial verticals. We specialize in consulting assignments and business research across high growth markets, cutting edge technologies and newer applications. Our 850 fulltime analyst and SMEs at MarketsandMarkets are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors.
M&M’s flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets. The new included chapters on Methodology and Benchmarking presented with high quality analytical infographics in our reports gives complete visibility of how the numbers have been arrived and defend the accuracy of the numbers.
We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.
Subscribe Reports from Healthcare Domain @ http://www.marketsandmarkets.com/Subscription.html
Unit No. 802, 8th Floor,
Tower - 7, Magarpatta City SEZ,
Hadapsar, Pune – 411013,
Visit MarketsandMarkets Blog @ http://mnmblog.org/market-research/healthcare/biotechnology
Connect with us on LinkedIn @ http://www.linkedin.com/company/marketsandmarkets